The DNA Sequencing market size is expected to reach USD 9.9 billion by 2030, from USD 8.6 billion in 2022, growing at a compound annual growth rate (CAGR) of 14.6% during the forecast period from 2023 to 2030.
The DNA sequencing market is growing significantly mainly due to the increasing prevalence of genetic diseases. The number of individuals suffering from diseases such as cancer, Alzheimer's disease, and cystic fibrosis has increased significantly, increasing the demand for accurate and efficient DNA sequencing methods for diagnosis and treatment. According to the World Health Organization (WHO), every year around 240,000 newborns worldwide die from congenital disorders within 28 days of birth, with genetic disorders being the main cause of these unfortunate events. As a result, there has been a notable surge in the adoption of DNA sequencing technologies and technologies for diagnosing and managing genetic diseases, and this trend is expected to continue in the future, fueling further growth of the DNA sequencing market.
Download Free Sample Report - https://www.marketdigits.com/request/sample/116
Moreover, the DNA sequencing market is growing rapidly. There is a growing preference for personalized medicine within the healthcare sector by both healthcare providers and patients. The trend of adopting personalized medicine as a treatment approach is on the rise and is expected to continue to grow. Personalized medicine involves tailoring medical interventions to meet the unique needs of individual patients, and DNA sequencing plays a pivotal role in its advancement. A profound understanding of genetics is essential in the area of personalized medicine, and DNA sequencing is an indispensable tool in this area. Researchers are using DNA sequencing to identify genetic mutations that contribute to tumor growth, enabling the development of precisely targeted treatments for personalized medical treatments. The market is witnessing accelerating expansion as personalized medicine solidifies its position as a key application for DNA sequencing.
Key developments in the DNA sequencing market
- Advances in next-generation sequencing (NGS): NGS technology has made significant improvements, increasing sequencing speed and accuracy and reducing cost per base. This democratizes DNA sequencing, making it more accessible for research, clinical diagnosis, and personalized medicine.
- Single Molecule Sequencing: New single molecule sequencing technologies, such as PacBio and Oxford Nanopore, provide the ability to read longer DNA fragments, enabling the study of complex genetic, genetic, and structural variations. Variants that were previously difficult to analyze, epigenetics
- Clinical applications: DNA sequencing is increasingly used in clinical settings to diagnose genetic diseases, predict disease risk, and guide targeted therapies. The market has seen a surge in clinical sequencing services and the integration of genomics into routine healthcare.
- AI and bioinformatics: The integration of artificial intelligence (AI) and advanced bioinformatics tools has accelerated the interpretation of sequencing data. Machine learning algorithms can identify relevant genetic variants to support disease diagnosis, drug discovery, and personalized treatment plans.
- Global Expansion: The DNA sequencing market has witnessed global expansion with increasing adoption in regions outside North America and Europe. Emerging markets such as Asia Pacific are playing a key role, driven by growth in research initiatives, healthcare investments, and genomics research.
Get Discount on Report - https://www.marketdigits.com/request/discount/116
major players
Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies Ltd., Macron, Inc., Perkin Elmer, Inc. , Pacific Biosciences of California, Inc., BGI, Bio-Rad Laboratories, Inc., Myriad Genetics, PierianDx, Intrexon Bioinformatics Germany GmbH, Eurofins Scientific and others.
“Thermo Fisher, Pfizer Team on Global Access to Cancer DNA Testing” Key categories include:
Here are:
- By product:instrument
Expendables
service
- By technology:
3rd generation DNA sequencingSingle Molecule Real-Time Sequencing (SMRT)
Nanopore sequencing
next-generation sequencingWhole genome sequencing (WGS)
Whole exome sequencing (WES)
Targeted sequencing and resequencing
Sanger sequencing
etc
- By workflow:Pre-sequencing
sequencing
data analysis
- By application:clinical investigation
oncology
Forensic & Agricultural Genomics
reproductive health
HLA typing
consumer genomics
etc
- By end use:clinical research
academic research
Biotechnology & Pharmaceutical Companies
Hospital & Clinic
etc
- By region
North AmericaUs
Canada
latin americabrazil
Mexico
Argentina
Rest of Latin America
europeuk
germany
france
Italy
Spain
russia
Rest of Europe
Asia Pacificchina
japan
India
korea
Asia Pacific region
Middle East and AfricaUAE
Saudi Arabia
Israel
south africa
Middle East and Rest of Africa
Request an inquiry before purchasing - https://www.marketdigits.com/request/enquiry-before-buying/116
Key Questions Covered in the Report
- What are the growth opportunities in the DNA Sequencing market?
- What are the key raw materials used in manufacturing the DNA Sequencing Market?
- What are the key factors influencing market dynamics?
- What are some of the key challenges and constraints facing the industry?
- Who are the key players operating in the market and what initiatives have they undertaken in the past years?
Frequently Asked Questions (FAQs) About DNA Sequencing Market:
- What is the demand for DNA sequencing?
- What are three things DNA sequencing is used for?
- What are the most widely used methods of DNA sequencing?
- How much DNA does next-generation sequencing require?
About MarketDigits:
MarketDigits is one of the leading business research and consulting firms that helps clients make operational and strategic decisions by leveraging emerging opportunities and revenue areas. to make. MarketDigits believes that markets are small places and the interface between suppliers and consumers. Therefore, we primarily focus on business research that includes not only the market but also the entire value chain.
We help businesses sustain in a highly competitive market by providing users with the most relevant and beneficial services. Strategic, tactical, operational data analysis & We leverage cutting-edge technology to report on the requirements of various industries, enabling our clients to gain better insights into the market and identify profitable opportunities and revenue growth areas.
Contact:
1248 CarMia Way Richmond,
VA 23235, United States.
Phone: +1 510-730-3200
Email: https://www.marketdigits.com